Evidence for a discrete UTP receptor in cardiac endothelial cells

British Journal of Pharmacology

Volumn 117, Issue 7, 1996, Pages 1572-1578

  Yang, Shumei ^a,b   Buxton, Iain L O ^a   Probert, Charles B ^a   Talbot, Jeffery N ^a   Bradley, Michael E ^a  

^a UNIVERSITY OF NEVADA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

ATP; Cardiac endothelial cells; Intracellular calcium; Pyrimidine receptor; UTP

Indexed keywords

2 METHYLTHIOADENOSINE TRIPHOSPHATE; ADENOSINE TRIPHOSPHATE; CALCIUM; PERTUSSIS TOXIN; PURINE P2Y RECEPTOR; SURAMIN; URIDINE TRIPHOSPHATE;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; DESENSITIZATION; DRUG POTENCY; ENDOCARDIUM; ENDOTHELIUM CELL; FEMALE; GUINEA PIG; NONHUMAN; PRIORITY JOURNAL;

EID: 0029942419     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb15323.x     Document Type: Article

References (30)

1. 2Y receptors. Trends, Pharmacol. Sci., 15, 280-281.
2. 2Y Trends Pharmacol. Sci., 15, 280-281.
3. 2Y purinergic receptor agonists and guanine nucleotides. J. Biol. Chem., 264, 884-890.
4. BROWN, H.A., LAZAROWSKI, E.R., BOUCHER, R.C. & HARDEN, T.K. (1991). Evidence that UTP and ATP regulate phospholipase C through a common extracellular 5′-nucleotide receptor in human airway epithelial cells. Mol. Pharmacol., 40, 648-655.
5. BURNSTOCK, G. (1993). Physiological and pathological roles of purines: An update. Drug Dev. Res., 28, 195-206.
6. 2-purinoceptor? Gen. Pharmacol., 16, 433-440.
7. FRY, G., PARSONS, T., HOAK, J., SAGE, H., GINGRICH, R.D., ERCOLANI, L., NGHIEM, D. & CZERVIONKE, R. (1984). Properties of cultured endothelium from adult human vessels. Arteriosclerosis, 4, 4-13.
8. GOETZ, U., DA PRADA, M. & PLETSCHER, A. (1971). Adenine-, guanine- and uridine-5′-phosphonucleotides in blood platelets and storage organelles of various species. J. Pharmacol. Exp. Ther., 178, 210-215.
9. GORDON, J.L. (1986). Extracellular ATP: effects, sources, and fate. Biochem. J., 233, 309-319.
10. HÄUSSINGER, D., STEHLE, T. & GEROK, W. (1987). Actions of extracellular UTP and ATP in perfused rat liver. A comparative study. Eur. J. Biochem., 167, 65-71.
11. 2X purinoceptors be classified pharmacologically? Trends Pharmacol. Sci., 16, 168-174.
12. KEPPENS, S. (1993). The complex interaction of ATP and UTP with isolated hepatocytes. How many receptors? Gen. Pharmacol., 24, 283-289.
13. LAZAROWSKI, E.R. & HARDEN, T.K. (1994). Identification of a uridine nucleotide-selective G-protein-linked receptor that activates phospholipase C. J. Biol. Chem., 269, 11830-11836.
14. LUSTIG, K.D., SHIAU, A.K., BRAKE, A.J. & JULIUS, D. (1993). Expression cloning of an ATP receptor from mouse neuroblastoma cells. Proc. Natl. Acad. Sci. U.S.A., 90, 5113-5117.
15. MANNIX, R.J., MOATTER, T., KELLEY, K.A. & GERRITSEN, M.E. (1993). Cellular signaling responses mediated by a novel nucleotide receptor in rabbit microvessel endothelium. Am. J. Physiol., 265, H675-H680.
16. 2U receptors in inositol phosphate response. Circ. Res., 72, 504-510.
17. NEES, S., GERBES, A.L. & GERLACH, E. (1981). Isolation, identification, and continuous culture of coronary endothelial cells from guinea pig heart. Eur. J. Cell. Biol. 24, 289-297.
18. O'CONNOR, S.E., DAINTY, I.A. & LEFF, P. (1991). Further subclassification of ATP receptors based on agonist studies. Trends Pharmacol. Sci., 12, 137-141.
19. PURKISS, J.R., WEST, D., WILKES, L.C., SCOTT, C., YARROW, P., WILKINSON, G.F. & BOARDER, M.R. (1994). Stimulation of phospholipase C in cultured microvascular endothelial cells from human frontal lobe by histimine, endothelin and purinoceptor agonists. Br. J. Pharmacol., 111, 1041-1046.
20. RALEVIC, V. & BURNSTOCK, G. (1991). Effects of purines and pyrimidines on the rat mesenteric arterial bed. Circ. Res., 69, 1583-1590.
21. SEIFERT, R. & SCHULTZ, G. (1989). Involvement of pyrimidinoceptors in the regulation of cell functions by uridine and by uracil nucleotides. Trends Pharmacol. Sci., 10, 365-369.
22. SIPMA, H., DEN HERTOG, A. & NELEMANS, A. (1994). The phospholipase C activating P2U purinoceptor also inhibits cyclic AMP formation in DDT1 MF-2 smooth muscle cells. Eur. J. Pharmacol. Mol. Pharmacol., 268, 431-437.
23. TRACEY, W.R. & PEACH, M.J. (1992). Differential muscarinic receptor mRNA expression by freshly isolated and cultured bovine aortic endothelial cells. Circ. Res., 70, 234-240.
24. URQUILLA, P.R. (1978). Prolonged contraction of isolated human and canine cerebral arteries induced by uridine 5′-triphosphate. Stroke, 9, 133-136.
25. URQUILLA, P.R., WESTFALL, D.P, GOTO, K. & FLEMING, W.W. (1978). The effects of ouabain and alterations in potassium concentration on the sensitivity to drugs and the membrane potential of the smooth muscle of the guinea-pig and rat vas deferens. J. Pharmacol. Exp. Ther., 207, 347-355.
26. VIALS, A.J. & BURNSTOCK, G. (1993). Effects of pyrimidines on the guinea-pig coronary vasculature. Br. J. Pharmacol., 110, 1091-1097.
27. VON KÜGELGEN, I., BÜLTMANN, R. & STARKE, K. (1990). Interaction of adenine nucleotides, UTP and suramin in mouse vas deferens: suramin-sensitive and suramin-insensitive components in the contractile effect of ATP. Naunyn-Schmied Arch. Pharmacol., 342, 198-205.
28. WILKINSON, G.F., PURKISS, J.R. & BOARDER, M.R. (1993). The regulation of aortic endothelial cells by purines and pyrimidines involves co-existing P2y-purinoceptors and nucleotide receptors linked to phospholipase C. Br. J. Pharmacol., 108, 689-693.
29. 2y purinoceptors and nucleotide receptors) coexisting on endothelial cells. Mol. Pharmacol., 45, 731-736.
30. YANG, S., CHEEK, D.J., WESTFALL, D.P. & BUXTON, I.L.O. (1994). Purinergic axis in cardiac blood vessels. Agonist-mediated release of ATP from cardiac endothelial cells. Circ. Res., 74, 401-407.